Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1970 Mar;29(2):164–172. doi: 10.1136/ard.29.2.164

Complement system in synovial fluids from patients with rheumatoid arthritis.

H Sonozaki, M Torisu
PMCID: PMC1010526  PMID: 4193524

Full text

PDF
164

Images in this article

169Image
on p.169
170Image
on p.170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORSOS T., DOURMASHKIN R. R., HUMPHREY J. H. LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS. Nature. 1964 Apr 18;202:251–252. doi: 10.1038/202251a0. [DOI] [PubMed] [Google Scholar]
  2. Cooper N. R., Becker E. L. Complement associated peptidase activity of guinea pig serum. I. Role of complement components. J Immunol. 1967 Jan;98(1):119–131. [PubMed] [Google Scholar]
  3. Dias da Silva W., Lepow I. H. Anaphylatoxin formation by purified human C'1 esterase. J Immunol. 1965 Dec;95(6):1080–1089. [PubMed] [Google Scholar]
  4. FOSTIROPOULOS G., AUSTEN K. F., BLOCH K. J. TOTAL HEMOLYTIC COMPLEMENT (CH50) AND SECOND COMPONENT OF COMPLEMENT (C2 HU) ACTIVITY IN SERUM AND SYNOVIAL FLUID. Arthritis Rheum. 1965 Apr;8:219–232. doi: 10.1002/art.1780080206. [DOI] [PubMed] [Google Scholar]
  5. GREEN H., BARROW P., GOLDBERG B. Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes. J Exp Med. 1959 Nov 1;110:699–713. doi: 10.1084/jem.110.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HEDBERG H. STUDIES ON THE DEPRESSED HEMOLYTIC COMPLEMENT ACTIVITY OF SYNOVIAL FLUID IN ADULT RHEUMATOID ARTHRITIS. Acta Rheumatol Scand. 1963;9:165–193. [PubMed] [Google Scholar]
  7. Hiramatsu S., Nagaki K., Inai S., Tanabe S. Immunoelectrophoretic studies on beta-1-E-globulin in human serum. Biken J. 1967 Sep;10(3):175–188. [PubMed] [Google Scholar]
  8. Inai S., Fujikawa K., Nagaki K., Ozono N., Ishida S. Serum level of the fourth component of complement in various diseases. Biken J. 1967 Jun;10(2):65–87. [PubMed] [Google Scholar]
  9. Inoue K., Nelson R. A., Jr The isolation and characterization of a new component of hemolytic complement, C'3e. J Immunol. 1965 Aug;95(2):355–367. [PubMed] [Google Scholar]
  10. Jensen J. Anaphylatoxin in its relation to the complement system. Science. 1967 Mar 3;155(3766):1122–1123. doi: 10.1126/science.155.3766.1122. [DOI] [PubMed] [Google Scholar]
  11. MUELLER-EBERHARD H. J., BIRO C. E. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1963 Sep 1;118:447–466. doi: 10.1084/jem.118.3.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MUELLER-EBERHARD H. J., LEPOW I. H. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 May 1;121:819–833. doi: 10.1084/jem.121.5.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MUSCHEL L. H., TREFFERS H. P. Quantitative studies on the bactericidal actions of serum and complement. II. Some implications for the mechanism of the bactericidal reaction. J Immunol. 1956 Jan;76(1):11–19. [PubMed] [Google Scholar]
  14. Müller-Eberhard H. J., Polley M. J., Calcott M. A. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med. 1967 Feb 1;125(2):359–380. doi: 10.1084/jem.125.2.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. NELSON R. A., Jr The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 1953 Dec 18;118(3077):733–737. doi: 10.1126/science.118.3077.733. [DOI] [PubMed] [Google Scholar]
  16. NISHIOKA K. Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence. J Immunol. 1963 Jan;90:86–97. [PubMed] [Google Scholar]
  17. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  18. PEKIN T. J., Jr, ZVAIFLER N. J. HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID. J Clin Invest. 1964 Jul;43:1372–1382. doi: 10.1172/JCI105013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
  20. Torisu M., Arata M., Majima H. Low reactivity of human complement in health adults. Jpn J Exp Med. 1966 Apr;36(2):251–253. [PubMed] [Google Scholar]
  21. Torisu M., Arata M., Sonozaki H., Majima H. C'3c deficient human sera with a beta-1c precipitin line. J Immunol. 1967 Sep;99(3):629–636. [PubMed] [Google Scholar]
  22. Torisu M., Sonozaki H., Shiraishi S., Nishioka K. Purification of C'3 inactivator from human serum. Nature. 1968 Jun 22;218(5147):1163–1164. doi: 10.1038/2181163a0. [DOI] [PubMed] [Google Scholar]
  23. Ward P. A., Cochrane C. G., Muller-Eberhard H. J. Further studies on the chemotactic factor of complement and its formation in vivo. Immunology. 1966 Aug;11(2):141–153. [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES